Please wait...
About This Project
OncoSynergy, Inc.
The Ebola outbreak in west Africa has been declared a global emergency by the WHO with over 1,000 victims and no approved therapies. OncoSynergy is developing a readily manufactured experimental cancer drug, OS2966, which coincidentally targets the receptor hijacked by ebola to infect cells. This project aims to demonstrate that OS2966 inhibits ebola infection of human cells thus providing the impetus for expediting OS2966 for treatment of ebola.
Recent Lab Notes From This Project
Browse Other Projects on Experiment
Related Projects
Do zoonotic pathogens exist in Fijian bats and if so what are the risks of exposure to humans?
Interactions between humans and bats can be both beneficial and detrimental. Habitat loss worldwide has increased...
Dogs, Cats, and Scats: Saving Jaguars, One Poop at a Time
The goal of our project is to improve connectivity of jaguar habitat in southern Mexico, an area of highly threatened...
